Table 2.
Tumour | Tissue |
Time of sampling after injection (h) |
||||
---|---|---|---|---|---|---|
24 | 48 | 72 | 96 | 168 | ||
HT-29 | Blood | 7.98 ± 0.89 | 5.97 ± 1.71 | 4.48 ± 1.70 | 4.65 ± 0.36 | 2.24 ± 1.77 |
Tumour | 11.90 ± 3.22 | 19.32 ± 3.58 | 18.69 ± 7.26 | 15.88 ± 4.37 | 13.29 ± 6.48 | |
Liver | 13.67 ± 1.65 | 13.35 ± 1.16 | 16.02 ± 1.60 | 12.08 ± 1.68 | 11.67 ± 1.14 | |
Spleen | 9.16 ± 1.25 | 9.80 ± 3.48 | 10.52 ± 1.85 | 11.95 ± 3.69 | 8.63 ± 3.33 | |
Kidney | 7.95 ± 0.55 | 7.00 ± 1.04 | 6.62 ± 0.36 | 5.12 ± 0.58 | 3.69 ± 1.10 | |
Lungs | 4.42 ± 0.56 | 3.53 ± 0.61 | 3.53 ± 0.77 | 3.44 ± 0.36 | 1.74 ± 0.94 | |
Heart | 2.60 ± 0.31 | 2.00 ± 0.25 | 1.98 ± 0.52 | 1.79 ± 0.28 | 1.01 ± 0.49 | |
Femur | 1.71 ± 0.54 | 1.94 ± 0.22 | 1.86 ± 0.34 | 1.70 ± 0.23 | 1.13 ± 0.43 | |
LS-174T | Blood | 11.69 ± 1.47 | 9.09 ± 0.81 | 6.83 ± 2.44 | 4.78 ± 1.98 | 3.10 ± 2.02 |
Tumour | 13.27 ± 8.40 | 44.08 ± 9.53 | 36.68 ± 20.00 | 29.28 ± 4.77 | 16.03 ± 6.40 | |
Liver | 5.76 ± 1.41 | 4.80 ± 2.09 | 4.11 ± 0.95 | 4.94 ± 1.95 | 2.83 ± 0.61 | |
Spleen | 4.28 ± 2.27 | 5.61 ± 1.04 | 5.16 ± 0.47 | 4.97 ± 1.33 | 3.45 ± 0.49 | |
Kidney | 4.81 ± 0.67 | 4.43 ± 0.68 | 3.26 ± 0.56 | 2.63 ± 0.42 | 1.67 ± 0.37 | |
Lungs | 5.44 ± 0.64 | 4.07 ± 0.42 | 3.18 ± 0.93 | 2.51 ± 1.03 | 1.55 ± 0.96 | |
Heart | 3.41 ± 0.62 | 2.64 ± 0.41 | 2.36 ± 0.66 | 1.72 ± 0.57 | 1.12 ± 0.62 | |
Femur | 1.35 ± 0.17 | 1.51 ± 017 | 1.23 ± 0.13 | 1.23 ± 0.21 | 0.80 ± 0.26 | |
SHAW | Blood | 10.54 ± 1.76 | 9.73 ± 1.05 | 5.79 ± 1.88 | 6.27 ± 2.60 | 4.12 ± 1.51 |
Tumour | 20.50 ± 13.22 | 23.26 ± 11.09 | 28.08 ± 12.43 | 29.35 ± 7.40 | 25.57 ± 5.61 | |
Liver | 5.21 ± 1.45 | 4.92 ± 1.45 | 4.93 ± 2.45 | 4.51 ± 0.39 | 3.45 ± 1.06 | |
Spleen | 3.95 ± 0.98 | 4.49 ± 0.93 | 3.57 ± 0.77 | 3.87 ± 1.29 | 3.45 ± 0.72 | |
Kidney | 3.32 ± 0.67 | 3.39 ± 0.40 | 2.28 ± 0.59 | 2.43 ± 0.78 | 1.77 ± 0.36 | |
Lungs | 5.27 ± 2.62 | 4.69 ± 0.54 | 3.00 ± 0.84 | 3.15 ± 1.38 | 2.29 ± 0.61 | |
Heart | 3.43 ± 0.94 | 3.33 ± 0.61 | 1.84 ± 0.55 | 2.34 ± 0.84 | 1.13 ± 0.22 | |
Femur | 1.76 ± 1.41 | 1.38 ± 0.17 | 1.01 ± 0.33 | 0.93 ± 0.45 | 0.92 ± 0.23 | |
SKOV-3 | Blood | 11.07 ± 1.93 | 8.57 ± 1.81 | 6.95 ± 1.75 | 4.87 ± 1.09 | 3.30 ± 0.71 |
Tumour | 21.63 ± 18.14 | 24.07 ± 6.46 | 30.81 ± 5.44 | 27.50 ± 9.31 | 23.38 ± 4.28 | |
Liver | 6.31 ± 2.90 | 5.74 ± 1.01 | 6.50 ± 1.31 | 3.45 ± 0.94 | 3.76 ± 0.99 | |
Spleen | 6.02 ± 3.07 | 5.32 ± 0.71 | 4.71 ± 0.66 | 3.52 ± 0.57 | 3.14 ± 0.53 | |
Kidney | 4.43 ± 0.59 | 4.18 ± 1.17 | 3.11 ± 0.48 | 2.50 ± 0.39 | 1.80 ± 0.25 | |
Lungs | 5.36 ± 1.01 | 4.26 ± 0.86 | 3.56 ± 0.89 | 3.05 ± 0.80 | 1.78 ± 0.29 | |
Heart | 3.36 ± 0.52 | 2.65 ± 0.45 | 2.19 ± 0.60 | 1.49 ± 0.23 | 1.11 ± 0.23 | |
Femur | 1.49 ± 0.23 | 1.36 ± 0.19 | 1.22 ± 0.23 | 0.99 ± 0.19 | 0.81 ± 0.15 |
Athymic mice bearing human tumour xenografts were injected (i.v.) with 111In-panitumumab (∼7.5 µCi). The mice were killed by exsanguination; the tumour, blood and tissues were removed, weighed, and the radioactivity measured. The values represent the average percentage of injected dose per gram of tissue (%ID·g−1) with standard deviations.